E-Folder - Business

Mentoring Success Secrets? … key questions to ask.

Mentoring has proven itself to be an effective tool to attract and retain good people. A question on the lips of many HR professionals today is: What are the secrets to ensuring a great mentoring program? Answers abound, sometimes it

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

's about ensuring a corporate fit, getting senior management buy-in, proper selection, matching, and proper training for all involved.

So how do you ensure mentoring program success? Looking at mentoring program standards and benchmarks is a good place to start. Based on Oystercorp’

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

experience of delivering mentoring programs globally, we have developed the following diagnostic tool, to ensure organisations considering mentoring ask themselves the right questions. These key questions will help you clarify your program objectives and get you thinking about effe

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ctive areas of mentoring program implementation. We recommend that program managers (together with potential stake-holders), go through and thoroughly answer the below questions. Asking these questions will help you get your mentoring program off to a good start.

Mentoring Program I

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

plementation stages

These questions are set out under the following ten areas of Mentoring program implementation.

1. Design and development
2. Organisational alignment
3. Participants and stakeholders
4. Program structure
5. Program promotion
6. Selection an

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

d matching
7. Resourcing
8. Participant training
9. Monitoring and evaluating
10. Roll-out

1. Design and development

What are the objectives of the program? This is the most important question of the design phase. You should also consider What do you want to

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

accomplish? How do you plan to accomplish these things? Who is the target population (by age, gender, geography, income, etc.)? What would success look like? – to mentees, mentors, the organization?

Create a simple statement that describes the program objectives. For example, ”The

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

mentoring objective is to groom 12 new managers as part of our succession strategy”. Answer these questions about your statement: Is it realistic? Is it clear and concise? Does it reflect the values and beliefs of your organisation? Does it reflect the needs of participants?

2.

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

rganisational alignment

What are the organisational values, strategies the program supports? What other HR/organisational initiatives is the program aligned with?

3. Resourcing

Where will the program budget sit? Who will manage this?

4. Participants and stakeholders

Who is your

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

most senior sponsor? Who are your mentees? mentors? Will you involve line managers to be involved? If so how? Who are the people who will drive/promote this program? Your support team (steering committee, program manager(s), champions)

5. Program structure

What type of mentoring

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

will be offered? (i.e traditional, peer, group, reverse). What model will you use, (one:to:one, one-to-many,group)? What will the structure of meetings be? (how often how long, when, where). What (if any) technology will be used to support the mentoring? (email, telephone, Ementori

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

g, telementoring etc.) How long do you expect mentoring matches to continue?

6. Program promotion

How will you promote the program? Will you have a launch? If so what will this look like? What resources will you use for promoting the program? (i.e. website, intranet, Ezine, comp

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

any newsletter, other promotional forums such as meetings, presentations) How will we promote the program results?

7. Selection and matching

How will participants be recruited and selected? Who will manage this process? What recognition will there be for program participation? H

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

w will mentors and mentees be matched? What tools, assessment criteria will we use to assist the process?

8. Participant Training

Who will provide the orientation and training? What is the best timing for this? What time commitment is reasonable for the workshops? What other act

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ivities will be a part of this program? (social etc.) What other curriculum will be used to support the training? (on-line resources, special project etc.). How will the partnerships be supported and monitored? How will participants be supported to keep up the momentum? How will w

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

mark the completion of the facilitated phase of the program?

9. Monitoring and Evaluating the Program

How will we measure success? What are the program objectives we will be evaluating the program against? What outcomes do we want for mentees, mentors and the organisation? How

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

will we monitor progress of participants throughout the program? How will we evaluate the program at completion? How will we evaluate this ? (i.e. participants self-assessment etc) How will you evaluate? (how, frequency etc.) How will program information be kept and managed?

10.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

Roll-out

What considerations do we need to have for roll out? What changes would we make to the program structure? Where would we next implement the program? How would we retain control of the program during the roll-out phase? (Go through the complete list of questions for roll o

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ut).

And finally …

Given the unique culture of this organisation, what other questions do we need to ask ourselves?

Implementing a mentoring program isn’t easy but it can be made simpler by following the 10 stages of Mentoring Success. Secrets to mentoring success include putting

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

he right foundation in place. This involves asking some important key questions with your stakeholders and anyone involved in the program planning. Implementing these key questions will help you clarify your objectives and get your mentoring program off to the best possible start

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/45518/e-folder-Mentoring-Success-Secrets.html">Mentoring Success Secrets</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/45518/e-folder-Mentoring-Success-Secrets.html]Mentoring Success Secrets[/url]

Offering coupons are a common and easy way to attract new or old clients to your salon, day spa or medical spa. But what kind of client are you really attracting? And are you profitably providing that service once the coupon is redeemed? Use these tips to make sure your clients are paying you for the service, and you are not paying them to walk in the door.

Many businesses give gifts to their clients at holiday time, such as tins of different flavored popcorn or baskets of candies or baked goods. It is a way for the company to thank the clients for their business throughout the year.

Can you tell me, aside from all the obvious such as positive attitude, outgoing personalities, sense of teaching, etc.,etc., what is the one quality that every great leader has in common?

Tags

Links

E-Folder - Mentoring Success Secrets

Related Articles: